Noninvasix Inc. received a breakthrough device designation from the FDA for its noninvasive Livox central venous oxygenation monitor, which allows real-time monitoring of central venous oxygen ...
Background: Therapeutic hypothermia (TH) is the only approved therapy for victims of sudden cardiac arrest who have a return of spontaneous circulation but have post-cardiac arrest syndrome (PCAS).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback